Immunomedics (IMMU) Reports Q2 Loss of $0.02
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Costs of goods sold: 255.11K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Costs of goods sold: 255.11K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q2 EPS of ($0.02), versus ($0.23) reported last year. Revenue for the quarter came in at $600 thousand, versus $40 thousand reported last year.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
